Cargando…
Computational discovery and experimental validation of novel drug targets in immuno-oncology
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649332/ http://dx.doi.org/10.1186/2051-1426-3-S2-P184 |
_version_ | 1782401335137665024 |
---|---|
author | Levy, Ofer Machelnkin, Arthur Rotman, Galit Toporik, Amir Cojocaro, Gady Dassa, Liat Vaknin, Ilan Liang, Spencer Hunter, John Neria, Eyal Levin, Zurit |
author_facet | Levy, Ofer Machelnkin, Arthur Rotman, Galit Toporik, Amir Cojocaro, Gady Dassa, Liat Vaknin, Ilan Liang, Spencer Hunter, John Neria, Eyal Levin, Zurit |
author_sort | Levy, Ofer |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4649332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46493322015-11-24 Computational discovery and experimental validation of novel drug targets in immuno-oncology Levy, Ofer Machelnkin, Arthur Rotman, Galit Toporik, Amir Cojocaro, Gady Dassa, Liat Vaknin, Ilan Liang, Spencer Hunter, John Neria, Eyal Levin, Zurit J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649332/ http://dx.doi.org/10.1186/2051-1426-3-S2-P184 Text en Copyright © 2015 Levy et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Levy, Ofer Machelnkin, Arthur Rotman, Galit Toporik, Amir Cojocaro, Gady Dassa, Liat Vaknin, Ilan Liang, Spencer Hunter, John Neria, Eyal Levin, Zurit Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title | Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title_full | Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title_fullStr | Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title_full_unstemmed | Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title_short | Computational discovery and experimental validation of novel drug targets in immuno-oncology |
title_sort | computational discovery and experimental validation of novel drug targets in immuno-oncology |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649332/ http://dx.doi.org/10.1186/2051-1426-3-S2-P184 |
work_keys_str_mv | AT levyofer computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT machelnkinarthur computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT rotmangalit computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT toporikamir computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT cojocarogady computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT dassaliat computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT vakninilan computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT liangspencer computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT hunterjohn computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT neriaeyal computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology AT levinzurit computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology |